应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
MRX Marex Group plc
盘前交易 05-27 06:08:59 EDT
54.25
+1.05
+1.97%
最高
54.96
最低
52.80
成交量
52.79万
今开
53.39
昨收
53.20
日振幅
4.06%
总市值
39.02亿
流通市值
27.98亿
总股本
7,193万
成交额
2,846万
换手率
1.02%
流通股本
5,158万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
财报前瞻｜Marex Group plc本季营收预计增49.67%，机构偏多
财报Agent · 04-29
财报前瞻｜Marex Group plc本季营收预计增49.67%，机构偏多
Marex Group Plc盘中异动 早盘大幅下挫5.12%
市场透视 · 03-03
Marex Group Plc盘中异动 早盘大幅下挫5.12%
财报前瞻｜Marex Group plc本季度营收预计增34.53%，并购强化做市平台
财报Agent · 02-24
财报前瞻｜Marex Group plc本季度营收预计增34.53%，并购强化做市平台
Marex Group Plc盘中异动 急速下挫5.17%
市场透视 · 2025-03-10
Marex Group Plc盘中异动 急速下挫5.17%
高盛：维持Marex Group(MRX.US)评级，由买入调整至买入评级, 目标价由36.00美元调整至40.00美元。
金融界 · 2025-03-08
高盛：维持Marex Group(MRX.US)评级，由买入调整至买入评级, 目标价由36.00美元调整至40.00美元。
Marex Group(MRX.US)：2024年Q4财报实现营收4.156亿美元，前值为3.256亿美元，预期值为3.77亿美元；每股收益为0.76美元，前值为0.54美元，预期值为0.64美元。
金融界 · 2025-03-06
Marex Group(MRX.US)：2024年Q4财报实现营收4.156亿美元，前值为3.256亿美元，预期值为3.77亿美元；每股收益为0.76美元，前值为0.54美元，预期值为0.64美元。
Marex Group第四季度调整后每股收益$0.76 超过预期的$0.64，收入$4.156亿 超过预期的$3.7844亿
财报速递 · 2025-03-06
Marex Group第四季度调整后每股收益$0.76 超过预期的$0.64，收入$4.156亿 超过预期的$3.7844亿
Marex Group Plc盘中异动 大幅下挫6.38%
市场透视 · 2025-02-28
Marex Group Plc盘中异动 大幅下挫6.38%
【盟科药业：全资子公司盟科美国对Medpace提起诉讼】盟科药业公告称，公司全资子公司盟科美国于2025年2月24日收到美国俄亥俄州南区联邦地区法院西部分院起诉立案确认通知，盟科美国诉Medpace合同纠纷一案已完成起诉立案。盟科美国请求判令Medpace赔偿因违反合同义务和不当行为导致的损失、成本和费用以及利息，具体金额将在庭审中证明。目前案件尚未开庭审理，最终实际影响需以后续法院判决或执行结果为准。公司已完成注射用MRX-4的中国III期临床试验，本次诉讼事宜不涉及对该试验的影响。
金融界 · 2025-02-25
【盟科药业：全资子公司盟科美国对Medpace提起诉讼】盟科药业公告称，公司全资子公司盟科美国于2025年2月24日收到美国俄亥俄州南区联邦地区法院西部分院起诉立案确认通知，盟科美国诉Medpace合同纠纷一案已完成起诉立案。盟科美国请求判令Medpace赔偿因违反合同义务和不当行为导致的损失、成本和费用以及利息，具体金额将在庭审中证明。目前案件尚未开庭审理，最终实际影响需以后续法院判决或执行结果为准。公司已完成注射用MRX-4的中国III期临床试验，本次诉讼事宜不涉及对该试验的影响。
Marex Group Plc盘中异动 早盘急速下挫5.22%
市场透视 · 2025-01-10
Marex Group Plc盘中异动 早盘急速下挫5.22%
Piper Sandler：维持Marex Group(MRX.US)评级，由增持调整至增持评级, 目标价由32.00美元调整至40.00美元。
金融界 · 2025-01-07
Piper Sandler：维持Marex Group(MRX.US)评级，由增持调整至增持评级, 目标价由32.00美元调整至40.00美元。
盟科药业(688373.SH)：MRX-5临床试验申请获批准
智通财经 · 2025-01-03
盟科药业(688373.SH)：MRX-5临床试验申请获批准
Marex Group Plc盘中异动 早盘急速上涨5.33%报32.83美元
市场透视 · 2025-01-02
Marex Group Plc盘中异动 早盘急速上涨5.33%报32.83美元
盟科药业：该公司用于治疗非结核分枝杆菌感染的新药MRX-5获FDA授予孤儿药资格认定。
金融界 · 2025-01-02
盟科药业：该公司用于治疗非结核分枝杆菌感染的新药MRX-5获FDA授予孤儿药资格认定。
Marex Group Plc盘中异动 股价大涨5.35%报30.34美元
市场透视 · 2024-12-20
Marex Group Plc盘中异动 股价大涨5.35%报30.34美元
盟科药业(688373.SH)：MRX-5在澳大利亚Ⅰ期临床试验已完成并达到预期目标
智通财经 · 2024-10-24
盟科药业(688373.SH)：MRX-5在澳大利亚Ⅰ期临床试验已完成并达到预期目标
Marex Group Plc盘中异动 急速跳水8.82%
市场透视 · 2024-10-22
Marex Group Plc盘中异动 急速跳水8.82%
加载更多
公司概况
公司名称：
Marex Group plc
所属市场：
NASDAQ
上市日期：
--
主营业务：
Marex Group plc于2005年11月根据英格兰和威尔士法律成立。Marex是一家多元化的全球金融服务平台，为能源、大宗商品和金融市场的客户提供必要的流动性、市场准入和基础设施服务。他们通过将客户连接到全球交易所并提供一系列执行服务，为客户提供关键服务。
发行价格：
--
{"stockData":{"symbol":"MRX","market":"US","secType":"STK","nameCN":"Marex Group plc","latestPrice":54.25,"timestamp":1779825600000,"preClose":53.2,"halted":0,"volume":527915,"delay":0,"changeRate":0.019736842105263105,"floatShares":51575700,"shares":71930900,"eps":4.367713,"marketStatus":"盘前交易","change":1.05,"latestTime":"05-27 06:08:59 EDT","open":53.39,"high":54.96,"low":52.8,"amount":28461617.59707,"amplitude":0.040602,"askPrice":0,"askSize":0,"bidPrice":51.91,"bidSize":18,"shortable":3,"etf":0,"ttmEps":4.367713,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779888600000},"marketStatusCode":1,"adr":0,"listingDate":1714017600000,"exchange":"NASDAQ","adjPreClose":54.25,"dividendRate":0.011244,"postHourTrading":{"tag":"盘后","latestPrice":54.01,"preClose":54.25,"latestTime":"19:33 EDT","volume":22880,"amount":1240947.95,"timestamp":1779838400294,"change":-0.24,"changeRate":-0.004424,"amplitude":0.004608},"volumeRatio":0.7004547171105708,"impliedVol":0.3851,"impliedVolPercentile":0.056},"requestUrl":"/m/hq/s/MRX","defaultTab":"news","newsList":[{"id":"1142073288","title":"财报前瞻｜Marex Group plc本季营收预计增49.67%，机构偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1142073288","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142073288?lang=zh_cn&edition=full","pubTime":"2026-04-29 14:17","pubTimestamp":1777443464,"startTime":"0","endTime":"0","summary":"Marex Group plc将于2026年05月06日美股盘前发布2026财年第一季度业绩，本文梳理市场预测与关键看点。上季度Marex Group plc营收为5.72亿美元，同比增长37.66%；毛利率为100.00%；归属于母公司股东的净利润为8,530.00万美元，净利率14.91%；调整后每股收益为1.13美元，同比增长48.68%。近期覆盖Marex Group plc的机构观点以看多为主，看多比例显著高于看空。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Marex Group plc本季营收预计增49.67%，机构偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616553026","title":"Marex Group Plc盘中异动 早盘大幅下挫5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616553026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616553026?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:35","pubTimestamp":1772548541,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日22时35分，Marex Group Plc股票出现波动，股价大幅跳水5.12%。截至发稿，该股报41.57美元/股，成交量2.5297万股，换手率0.04%，振幅3.79%。Marex Group Plc股票所在的资本市场行业中，整体跌幅为1.79%。Marex Group Plc公司简介：Marex Group PLC提供多元化的金融服务平台，为能源、大宗商品和金融市场的客户提供必要的流动性、市场准入和基础设施服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303223541a44721d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303223541a44721d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4127","MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183730319","title":"财报前瞻｜Marex Group plc本季度营收预计增34.53%，并购强化做市平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1183730319","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183730319?lang=zh_cn&edition=full","pubTime":"2026-02-24 10:28","pubTimestamp":1771900101,"startTime":"0","endTime":"0","summary":"Marex Group plc将于2026年03月03日美股盘前发布2025财年第四季度及全年业绩，市场关注高增长预期与新并购带来的协同落地。市场一致预期本季度Marex Group plc营收约5.09亿美元，同比增长34.53%；调整后每股收益预计为1.02美元，同比增长60.51%。当前一致预期未披露毛利率与净利率的季度预测值，公司层面的净利润预测也未在公开预期中出现。若公司对本季度的明确指引涉及毛利率、净利率或净利润，将在财报发布时成为追加验证的重点。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Marex Group plc本季度营收预计增34.53%，并购强化做市平台","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518277931","title":"Marex Group Plc盘中异动 急速下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518277931?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613702,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Marex Group Plc股票出现波动，股价大幅跳水5.17%。截至发稿，该股报34.50美元/股，成交量3.1354万股，换手率0.04%，振幅1.95%。Marex Group Plc股票所在的资本市场行业中，整体跌幅为2.30%。Marex Group Plc公司简介：Marex Group PLC是一家提供多元化全球金融服务平台的公司，为能源、大宗商品和金融市场的客户提供必要的流动性、市场准入和基础设施服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213502a26a260b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213502a26a260b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4127","MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517459247","title":"高盛：维持Marex Group(MRX.US)评级，由买入调整至买入评级, 目标价由36.00美元调整至40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517459247","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517459247?lang=zh_cn&edition=full","pubTime":"2025-03-08 02:02","pubTimestamp":1741370578,"startTime":"0","endTime":"0","summary":"高盛：维持Marex Group(MRX.US)评级，由买入调整至买入评级, 目标价由36.00美元调整至40.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08020248605029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517159386","title":"Marex Group(MRX.US)：2024年Q4财报实现营收4.156亿美元，前值为3.256亿美元，预期值为3.77亿美元；每股收益为0.76美元，前值为0.54美元，预期值为0.64美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517159386","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517159386?lang=zh_cn&edition=full","pubTime":"2025-03-06 20:11","pubTimestamp":1741263104,"startTime":"0","endTime":"0","summary":"Marex Group(MRX.US)：2024年Q4财报实现营收4.156亿美元，前值为3.256亿美元，预期值为3.77亿美元；每股收益为0.76美元，前值为0.54美元，预期值为0.64美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06201148572371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150215492","title":"Marex Group第四季度调整后每股收益$0.76 超过预期的$0.64，收入$4.156亿 超过预期的$3.7844亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1150215492","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150215492?lang=zh_cn&edition=full","pubTime":"2025-03-06 20:06","pubTimestamp":1741262792,"startTime":"0","endTime":"0","summary":"Marex Group 报告季度每股收益为$0.76，超过分析师一致预期的$0.64，超出18.75%。与去年同期的每股收益$0.54相比，增长了40.74%。以上内容来自Benzinga Earnings专栏，原文如下：Marex Group reported quarterly earnings of $0.76 per share which beat the analyst consensus estimate of $0.64 by 18.75 percent. This is a 40.74 percent increase over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $415.60 million which beat the analyst consensus estimate of $378.44 million by 9.82 percent. This is a 27.64 percent i","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Marex Group第四季度调整后每股收益$0.76 超过预期的$0.64，收入$4.156亿 超过预期的$3.7844亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514320099","title":"Marex Group Plc盘中异动 大幅下挫6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320099?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:35","pubTimestamp":1740753314,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时35分，Marex Group Plc股票出现波动，股价大幅下跌6.38%。截至发稿，该股报34.50美元/股，成交量3.1503万股，换手率0.04%，振幅8.60%。Marex Group Plc股票所在的资本市场行业中，整体涨幅为0.54%。Marex Group Plc公司简介：Marex Group PLC是一家提供多元化全球金融服务平台的公司，为能源、大宗商品和金融市场的客户提供必要的流动性、市场准入和基础设施服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223514abe0ebc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223514abe0ebc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4127","MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514705049","title":"【盟科药业：全资子公司盟科美国对Medpace提起诉讼】盟科药业公告称，公司全资子公司盟科美国于2025年2月24日收到美国俄亥俄州南区联邦地区法院西部分院起诉立案确认通知，盟科美国诉Medpace合同纠纷一案已完成起诉立案。盟科美国请求判令Medpace赔偿因违反合同义务和不当行为导致的损失、成本和费用以及利息，具体金额将在庭审中证明。目前案件尚未开庭审理，最终实际影响需以后续法院判决或执行结果为准。公司已完成注射用MRX-4的中国III期临床试验，本次诉讼事宜不涉及对该试验的影响。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705049","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514705049?lang=zh_cn&edition=full","pubTime":"2025-02-25 16:51","pubTimestamp":1740473510,"startTime":"0","endTime":"0","summary":"盟科药业公告称，公司全资子公司盟科美国于2025年2月24日收到美国俄亥俄州南区联邦地区法院西部分院起诉立案确认通知，盟科美国诉Medpace合同纠纷一案已完成起诉立案。盟科美国请求判令Medpace赔偿因违反合同义务和不当行为导致的损失、成本和费用以及利息，具体金额将在庭审中证明。目前案件尚未开庭审理，最终实际影响需以后续法院判决或执行结果为准。公司已完成注射用MRX-4的中国III期临床试验，本次诉讼事宜不涉及对该试验的影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25165148371308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRX","BK1583","BK1141","BK4127","BK0239","688373","III","03347","BK4134","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502094860","title":"Marex Group Plc盘中异动 早盘急速下挫5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502094860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502094860?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:08","pubTimestamp":1736521689,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时08分，Marex Group Plc股票出现异动，股价快速下跌5.22%。截至发稿，该股报30.84美元/股，成交量3.1962万股，换手率0.05%，振幅2.94%。Marex Group Plc股票所在的资本市场行业中，整体跌幅为2.22%。Marex Group Plc公司简介：Marex Group PLC是一家提供多元化全球金融服务平台的公司，为能源、大宗商品和金融市场的客户提供必要的流动性、市场准入和基础设施服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230809a21d171e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230809a21d171e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4127","MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501204999","title":"Piper Sandler：维持Marex Group(MRX.US)评级，由增持调整至增持评级, 目标价由32.00美元调整至40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501204999","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501204999?lang=zh_cn&edition=full","pubTime":"2025-01-07 21:44","pubTimestamp":1736257450,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Marex Group(MRX.US)评级，由增持调整至增持评级, 目标价由32.00美元调整至40.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/07214447232346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500683161","title":"盟科药业(688373.SH)：MRX-5临床试验申请获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2500683161","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500683161?lang=zh_cn&edition=full","pubTime":"2025-01-03 15:34","pubTimestamp":1735889651,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盟科药业(688373.SH)公告，公司近日收到国家药品监督管理局签发的关于MRX-5片用于治疗对本品敏感的非结核分枝杆菌引起的感染的《药物临床试验批准通知书》。公告显示，MRX-5是一种新型苯并硼唑类抗生素，拟用于治疗分枝杆菌属，特别是由NTM引起的感染。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1233037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1576","MRX","BK1141","BK1583","BK4127","688373","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500363975","title":"Marex Group Plc盘中异动 早盘急速上涨5.33%报32.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500363975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500363975?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:06","pubTimestamp":1735830384,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时06分，Marex Group Plc股票出现异动，股价大幅拉升5.33%。截至发稿，该股报32.83美元/股，成交量19.4253万股，换手率0.28%，振幅4.32%。Marex Group Plc股票所在的资本市场行业中，整体涨幅为1.15%。Marex Group Plc公司简介：Marex Group PLC是一家提供多元化全球金融服务平台的公司，为能源、大宗商品和金融市场的客户提供必要的流动性、市场准入和基础设施服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102230624985903ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102230624985903ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRX","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500967779","title":"盟科药业：该公司用于治疗非结核分枝杆菌感染的新药MRX-5获FDA授予孤儿药资格认定。","url":"https://stock-news.laohu8.com/highlight/detail?id=2500967779","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500967779?lang=zh_cn&edition=full","pubTime":"2025-01-02 13:01","pubTimestamp":1735794072,"startTime":"0","endTime":"0","summary":"盟科药业：该公司用于治疗非结核分枝杆菌感染的新药MRX-5获FDA授予孤儿药资格认定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/02130147027829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4127","MRX","BK0239","688373"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492428160","title":"Marex Group Plc盘中异动 股价大涨5.35%报30.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492428160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492428160?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:52","pubTimestamp":1734709977,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时52分，Marex Group Plc股票出现异动，股价急速拉升5.35%。截至发稿，该股报30.34美元/股，成交量5.4067万股，换手率0.08%，振幅4.74%。Marex Group Plc股票所在的资本市场行业中，整体涨幅为0.86%。Marex Group Plc公司简介：Marex Group PLC是一家提供多元化全球金融服务平台的公司，为能源、大宗商品和金融市场的客户提供必要的流动性、市场准入和基础设施服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122023525895ea9df0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122023525895ea9df0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4127","MRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2477571627","title":"盟科药业(688373.SH)：MRX-5在澳大利亚Ⅰ期临床试验已完成并达到预期目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2477571627","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477571627?lang=zh_cn&edition=full","pubTime":"2024-10-24 15:46","pubTimestamp":1729755979,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盟科药业 发布公告，公司自主研发的新型苯并硼唑类抗菌药MRX-5在澳大利亚的Ⅰ期临床试验已于近日完成并达到预期目标。MRX-5属于新型抗耐药NTM感染新药，对常见的NTM致病菌具有良好的抗菌活性，且在动物试验和此次人体实验中显示出良好的安全性和药代动力学特性。本次临床研究结果表明，MRX-5在健康成人群体中显现出良好的安全性和耐受性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK1583","BK4127","MRX","BK0239","688373","BK1141","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2477337329","title":"Marex Group Plc盘中异动 急速跳水8.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477337329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477337329?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:31","pubTimestamp":1729603872,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时31分，Marex Group Plc股票出现波动，股价大幅下挫8.82%。Marex Group Plc股票所在的资本市场行业中，整体跌幅为0.49%。其相关个股中，Marketwise, Inc.、阿提夫控股、狮子集团控股涨幅较大，狮子集团控股、Marketwise, Inc.、老虎证券较为活跃，换手率分别为64.03%、5.85%、1.58%，振幅较大的相关个股有Marex Group Plc、Hive Digital Technologies Ltd、狮子集团控股，振幅分别为4.43%、3.92%、3.82%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222131129f56b912&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410222131129f56b912&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4127","MRX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.marex.com;www.marexspectron.com;www.marexsolutions.com","stockEarnings":[{"period":"1week","weight":-0.004},{"period":"1month","weight":0.0275},{"period":"3month","weight":0.3038},{"period":"6month","weight":0.5598},{"period":"1year","weight":0.2093},{"period":"ytd","weight":0.4142}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.0513},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1043},{"period":"1year","weight":0.2961},{"period":"ytd","weight":0.1007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marex Group plc于2005年11月根据英格兰和威尔士法律成立。Marex是一家多元化的全球金融服务平台，为能源、大宗商品和金融市场的客户提供必要的流动性、市场准入和基础设施服务。他们通过将客户连接到全球交易所并提供一系列执行服务，为客户提供关键服务。","exchange":"NASDAQ","name":"Marex Group plc","nameEN":"Marex Group plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marex Group plc(MRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marex Group plc(MRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marex Group plc,MRX,Marex Group plc股票,Marex Group plc股票老虎,Marex Group plc股票老虎国际,Marex Group plc行情,Marex Group plc股票行情,Marex Group plc股价,Marex Group plc股市,Marex Group plc股票价格,Marex Group plc股票交易,Marex Group plc股票购买,Marex Group plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marex Group plc(MRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marex Group plc(MRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}